Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 456

1.

Live attenuated oral cholera vaccines.

Ryan ET, Calderwood SB, Qadri F.

Expert Rev Vaccines. 2006 Aug;5(4):483-94. Review.

PMID:
16989629
[PubMed - indexed for MEDLINE]
2.

A review of the current status of enteric vaccines.

Levine MM, Noriega F.

P N G Med J. 1995 Dec;38(4):325-31. Review.

PMID:
9522876
[PubMed - indexed for MEDLINE]
3.

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.

Taylor DN, Tacket CO, Losonsky G, Castro O, Gutierrez J, Meza R, Nataro JP, Kaper JB, Wasserman SS, Edelman R, Levine MM, Cryz SJ.

Infect Immun. 1997 Sep;65(9):3852-6.

PMID:
9284163
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Oral vaccines against cholera: lessons from Vietnam and elsewhere.

Levine MM.

Lancet. 1997 Jan 25;349(9047):220-1.

PMID:
9014902
[PubMed - indexed for MEDLINE]
5.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

PMID:
19146897
[PubMed - indexed for MEDLINE]
6.

Cholera vaccines.

Ryan ET, Calderwood SB.

Clin Infect Dis. 2000 Aug;31(2):561-5. Epub 2000 Sep 7. Review.

PMID:
10987721
[PubMed - indexed for MEDLINE]
Free Article
7.

Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.

Chowdhury MI, Sheikh A, Qadri F.

Expert Rev Vaccines. 2009 Dec;8(12):1643-52. doi: 10.1586/erv.09.137. Review.

PMID:
19943759
[PubMed - indexed for MEDLINE]
9.

Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.

Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelman R, Fasano A, Michalski J, Kaper JB, Levine MM.

J Infect Dis. 1993 Dec;168(6):1536-40.

PMID:
8245542
[PubMed - indexed for MEDLINE]
10.

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.

Suharyono, Simanjuntak C, Witham N, Punjabi N, Heppner DG, Losonsky G, Totosudirjo H, Rifai AR, Clemens J, Lim YL, et al.

Lancet. 1992 Sep 19;340(8821):689-94.

PMID:
1355798
[PubMed - indexed for MEDLINE]
11.

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.

Kenner JR, Coster TS, Taylor DN, Trofa AF, Barrera-Oro M, Hyman T, Adams JM, Beattie DT, Killeen KP, Spriggs DR, et al.

J Infect Dis. 1995 Oct;172(4):1126-9.

PMID:
7561195
[PubMed - indexed for MEDLINE]
12.

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.

Clemens JD, Sack DA, Rao MR, Chakraborty J, Khan MR, Kay B, Ahmed F, Banik AK, van Loon FP, Yunus M, et al.

J Infect Dis. 1992 Nov;166(5):1029-34.

PMID:
1402014
[PubMed - indexed for MEDLINE]
13.

Live oral vaccines against cholera: an update.

Levine MM, Kaper JB.

Vaccine. 1993;11(2):207-12. Review.

PMID:
8438619
[PubMed - indexed for MEDLINE]
14.

Experience with registered mucosal vaccines.

Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF.

Vaccine. 2003 Jan 30;21(7-8):678-83. Review.

PMID:
12531339
[PubMed - indexed for MEDLINE]
15.

Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.

Viret JF, Dietrich G, Favre D.

Vaccine. 2004 Jun 23;22(19):2457-69. Review.

PMID:
15193410
[PubMed - indexed for MEDLINE]
16.

An oral B subunit: whole cell vaccine against cholera.

Holmgren J, Svennerholm AM, Jertborn M, Clemens J, Sack DA, Salenstedt R, Wigzell H.

Vaccine. 1992;10(13):911-4.

PMID:
1471411
[PubMed - indexed for MEDLINE]
17.

Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR.

Kaper JB, Michalski J, Ketley JM, Levine MM.

Infect Immun. 1994 Apr;62(4):1480-3.

PMID:
8132356
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[The excretion pattern and protective capacity in rabbits orally immunized with attenuated strains of Vibrio cholerae O1 biotype El Tor].

García Sánchez HM, García Imia L, Oliva Hernández R, Pérez Quiñoy JL, Cedré Marrero B, Domínguez Iriarte R, Benítez Robles J.

Rev Cubana Med Trop. 1998;50(2):115-9. Spanish.

PMID:
10349429
[PubMed - indexed for MEDLINE]
19.

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Tacket CO, Cohen MB, Wasserman SS, Losonsky G, Livio S, Kotloff K, Edelman R, Kaper JB, Cryz SJ, Giannella RA, Schiff G, Levine MM.

Infect Immun. 1999 Dec;67(12):6341-5.

PMID:
10569747
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.

Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, Hang PV, Rao MR.

Lancet. 1997 Jan 25;349(9047):231-5.

PMID:
9014909
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk